you are here:

RPG Life Sciences Ltd.

BSE: 532983 | NSE: RPGLIFE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE105J01010 | SECTOR: Pharmaceuticals

BSE Live

Feb 26, 16:00
415.00 -1.25 (-0.30%)
Volume
AVERAGE VOLUME
5-Day
4,203
10-Day
6,436
30-Day
13,035
4,362
  • Prev. Close

    416.25

  • Open Price

    395.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 26, 15:54
415.45 -0.75 (-0.18%)
Volume
AVERAGE VOLUME
5-Day
26,707
10-Day
52,165
30-Day
105,105
37,192
  • Prev. Close

    416.20

  • Open Price

    415.55

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    415.45 (55)

ANNOUNCEMENTS ON RPG Life

  • Jan 27, 2021 14:28 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter and nine months ended December 31, 2020. Kindly take this information on record.

  • Jan 25, 2021 19:04 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Please find enclosed herewith a copy of press release with respect to Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2020. Kindly take the above on record.

  • Jan 25, 2021 18:10 Source: BSE

    RPG Life Sciences - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Please find enclosed herewith intimation of issuance of duplicate share certificate(s) as received by us from Link Intime Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record.

  • Jan 25, 2021 17:58 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Change in Directorate

    The Board has appointed Mr. Rajat Bhargava (DIN:07752438) as an Additional and Non-Executive Director of the Company.

  • Jan 25, 2021 17:47 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

    Adoption of revised Code of Fair Disclosure (Including Determination of Legitimate Purpose), Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Person(s) ('Code').

  • Jan 25, 2021 17:44 Source: BSE

    RPG Life Sciences - Unaudited Financial Results For Quarter Ended December 31, 2020

    Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and nine months ended December 31, 2020 which were approved by the Board of Directors of the Company, at its meeting held on January 25, 2021 along with Limited Review Report issued by the Statutory Auditors of the Company.

  • Jan 25, 2021 17:39 Source: BSE

    RPG Life Sciences - Outcome Of The Board Meeting Held On January 25, 2021

    Outcome of the Board Meeting held on January 25, 2021

  • Jan 21, 2021 15:50 Source: BSE

    RPG Life Sciences - Clarification On Increase In Volume

    With reference to your above referred email dated January 21, 2021 seeking clarification on significant increase in the volume of security across Exchanges in the recent past, we wish to inform you that there are no events, information, announcements etc. that have a bearing on the operations/performance of the Company which includes price sensitive information, which is required to be disclosed to the stock exchanges pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Hence, we are unable to comment on the significant increase in the volume of Company's security across Exchanges, in the recent past. Further, we would like to reiterate that, as in the past, the Company would continue to inform stock exchanges regularly about any price sensitive information and to make it available on the website of the Company before the same is made public. Kindly request you to take the same on record.

  • Jan 21, 2021 11:53 Source: BSE

    RPG Life Sciences - Clarification sought from RPG Life Sciences Ltd

    The Exchange has sought clarification from RPG Life Sciences Ltd on January 21, 2021, with reference to Movement in Volume.The reply is awaited.

  • Jan 19, 2021 17:30 Source: BSE

    RPG Life Sciences - Shareholding for the Period Ended December 31, 2020

    RPG Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Jan 25, 2021
Remark : Quarterly Results